Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision history shows a new page version, from v3.5.2 to v3.5.3, indicating a minor update to the record's metadata.SummaryDifference0.1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the study record history.SummaryDifference0.1%
- Check57 days agoChange DetectedRevision v3.5.0 was added to the record history, replacing the previous v3.4.3 entry. This is a metadata update to the history and does not alter the study content or data displayed on the page.SummaryDifference0.1%
- Check64 days agoChange DetectedA new revision entry, v3.4.3, was added to the history. The prior entry, v3.4.2, was removed from the current view.SummaryDifference0.1%
- Check92 days agoChange DetectedRevision: v3.4.2 was added to the history, and the notice about a lapse in government funding as well as Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%
- Check100 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the record to Revision 3.4.1; the previous Revision 3.4.0 was removed. These changes are administrative and do not affect core study data, eligibility criteria, or the availability of results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%
Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.